Literature DB >> 20720045

Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors.

Kuangyu Shi1, Michael Souvatzoglou, Sabrina T Astner, Peter Vaupel, Fridtjof Nüsslin, Jan J Wilkens, Sibylle I Ziegler.   

Abstract

UNLABELLED: Several kinetic models have been proposed to assess the underlying oxygenation status behind hypoxia tracer uptake and have shown advantages, compared with static analysis, in discriminating hypoxic regions. However, the quantitative assessment of mathematic models that take into consideration clinical applications and their biologic nature is still challenging. We performed a feasibility study to assess hypoxia kinetic models using voxelwise cross-analysis between the uptake of the perfusion tracer (15)O-H(2)O and the hypoxia tracer (18)F-fluoroazomycin arabinoside ((18)F-FAZA).
METHODS: Five patients with advanced head and neck cancer were included. For each patient, dynamic sequences of (15)O-H(2)O for 5 min and (18)F-FAZA for 60 min were acquired consecutively after injections of approximately 1 GBq and 300 MBq of each tracer, respectively. The compartment model, Thorwarth model, Patlak plot, Logan plot, and Cho model were applied to model the process of tracer transport and accumulation under hypoxic conditions. The standard 1-tissue-compartment model was used to compute a perfusion map for each patient. The hypoxia kinetic models were based on the assumption of a positive correlation between tracer delivery and perfusion and a negative (inverse) correlation between tracer accumulation (hypoxia) and perfusion.
RESULTS: Positive correlations between tracer delivery and perfusion were observed for the Thorwarth and Cho models in all patients and for the reversible and irreversible 2-compartment models in 4 patients. Negative correlations between tracer accumulation and perfusion were observed for the reversible 2-compartment model in all patients and for the irreversible 2-compartment model and Cho model in 4 patients. When applied to normal skeletal muscle, the smallest correlation variance over all 5 patients was observed for the reversible 2-compartment model.
CONCLUSION: Hypoxia kinetic modeling delivers different information from static measurements. Different models generate different results for the same patient, and they even can lead to opposite physiologic interpretations. On the basis of our assessment of physiologic precision and robustness, the reversible 2-compartment model corresponds better to the expectations of our assumptions than the other investigated models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720045     DOI: 10.2967/jnumed.109.074336

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

Review 1.  Kinetic modeling in PET imaging of hypoxia.

Authors:  Fan Li; Jesper T Joergensen; Anders E Hansen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

Review 2.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

3.  Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Authors:  Eline E Verwer; Floris H P van Velden; Idris Bahce; Maqsood Yaqub; Robert C Schuit; Albert D Windhorst; Pieter Raijmakers; Adriaan A Lammertsma; Egbert F Smit; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

4.  18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.

Authors:  Mark Muzi; Lanell M Peterson; Janet N O'Sullivan; James R Fink; Joseph G Rajendran; Lena J McLaughlin; John P Muzi; David A Mankoff; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-06-25       Impact factor: 10.057

5.  Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

Authors:  Stephen R Bowen; Albert J van der Kogel; Marianne Nordsmark; Søren M Bentzen; Robert Jeraj
Journal:  Nucl Med Biol       Date:  2011-05-05       Impact factor: 2.408

Review 6.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Quantitative Analysis of [18F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry.

Authors:  Kuangyu Shi; Christine Bayer; Sabrina T Astner; Florian C Gaertner; Peter Vaupel; Markus Schwaiger; Sung-Cheng Huang; Sibylle I Ziegler
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

8.  Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Authors:  Florian C Maier; Manfred Kneilling; Gerald Reischl; Funda Cay; Daniel Bukala; Andreas Schmid; Martin S Judenhofer; Martin Röcken; Hans-Jürgen Machulla; Bernd J Pichler
Journal:  Radiat Oncol       Date:  2011-11-25       Impact factor: 3.481

Review 9.  Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy.

Authors:  Martin-Immanuel Bittner; Anca-Ligia Grosu
Journal:  Front Oncol       Date:  2013-08-28       Impact factor: 6.244

10.  The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.

Authors:  Mustafa Takesh
Journal:  ISRN Oncol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.